Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Serum monomeric laminin‐γ2 as a novel biomarker for hepatocellular carcinoma
by
Watanabe, Tsunamasa
, Yasuda, Hiroshi
, Koshikawa, Naohiko
, Oikawa, Ritsuko
, Kiyokawa, Hirofumi
, Otsubo, Takehito
, Seiki, Motoharu
, Yamamoto, Hiroyuki
, Itoh, Fumio
, Yoshida, Eisaku
, Yoshimura, Toru
, Matsumoto, Nobuyuki
, Okuse, Chiaki
, Ikeda, Hiroki
, Nakagawa, Masatoshi
in
Aged
/ Aged, 80 and over
/ Alcohol
/ Antigens
/ Area Under Curve
/ Biomarker
/ Biomarkers
/ Biomarkers - blood
/ Biomarkers, Tumor - blood
/ Blotting, Western
/ Carcinoma
/ Carcinoma, Hepatocellular - blood
/ Cell adhesion & migration
/ des‐gamma‐carboxy prothrombin
/ Diagnosis
/ Etiology
/ Female
/ Hepatitis
/ Hepatocellular carcinoma
/ Humans
/ Immunohistochemistry
/ Laboratories
/ Laminin
/ Laminin - blood
/ laminin‐γ2
/ Liver cancer
/ Liver diseases
/ Liver Neoplasms - blood
/ Luminescent Measurements
/ Male
/ Medical research
/ Middle Aged
/ NMR
/ Nuclear magnetic resonance
/ Original
/ Patients
/ Polypeptides
/ Protein Precursors - blood
/ Prothrombin
/ ROC Curve
/ Sensitivity and Specificity
/ Studies
/ Surveillance
/ Technology transfer
/ Tumors
/ Ultrasonic imaging
/ Viral infections
2017
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Serum monomeric laminin‐γ2 as a novel biomarker for hepatocellular carcinoma
by
Watanabe, Tsunamasa
, Yasuda, Hiroshi
, Koshikawa, Naohiko
, Oikawa, Ritsuko
, Kiyokawa, Hirofumi
, Otsubo, Takehito
, Seiki, Motoharu
, Yamamoto, Hiroyuki
, Itoh, Fumio
, Yoshida, Eisaku
, Yoshimura, Toru
, Matsumoto, Nobuyuki
, Okuse, Chiaki
, Ikeda, Hiroki
, Nakagawa, Masatoshi
in
Aged
/ Aged, 80 and over
/ Alcohol
/ Antigens
/ Area Under Curve
/ Biomarker
/ Biomarkers
/ Biomarkers - blood
/ Biomarkers, Tumor - blood
/ Blotting, Western
/ Carcinoma
/ Carcinoma, Hepatocellular - blood
/ Cell adhesion & migration
/ des‐gamma‐carboxy prothrombin
/ Diagnosis
/ Etiology
/ Female
/ Hepatitis
/ Hepatocellular carcinoma
/ Humans
/ Immunohistochemistry
/ Laboratories
/ Laminin
/ Laminin - blood
/ laminin‐γ2
/ Liver cancer
/ Liver diseases
/ Liver Neoplasms - blood
/ Luminescent Measurements
/ Male
/ Medical research
/ Middle Aged
/ NMR
/ Nuclear magnetic resonance
/ Original
/ Patients
/ Polypeptides
/ Protein Precursors - blood
/ Prothrombin
/ ROC Curve
/ Sensitivity and Specificity
/ Studies
/ Surveillance
/ Technology transfer
/ Tumors
/ Ultrasonic imaging
/ Viral infections
2017
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Serum monomeric laminin‐γ2 as a novel biomarker for hepatocellular carcinoma
by
Watanabe, Tsunamasa
, Yasuda, Hiroshi
, Koshikawa, Naohiko
, Oikawa, Ritsuko
, Kiyokawa, Hirofumi
, Otsubo, Takehito
, Seiki, Motoharu
, Yamamoto, Hiroyuki
, Itoh, Fumio
, Yoshida, Eisaku
, Yoshimura, Toru
, Matsumoto, Nobuyuki
, Okuse, Chiaki
, Ikeda, Hiroki
, Nakagawa, Masatoshi
in
Aged
/ Aged, 80 and over
/ Alcohol
/ Antigens
/ Area Under Curve
/ Biomarker
/ Biomarkers
/ Biomarkers - blood
/ Biomarkers, Tumor - blood
/ Blotting, Western
/ Carcinoma
/ Carcinoma, Hepatocellular - blood
/ Cell adhesion & migration
/ des‐gamma‐carboxy prothrombin
/ Diagnosis
/ Etiology
/ Female
/ Hepatitis
/ Hepatocellular carcinoma
/ Humans
/ Immunohistochemistry
/ Laboratories
/ Laminin
/ Laminin - blood
/ laminin‐γ2
/ Liver cancer
/ Liver diseases
/ Liver Neoplasms - blood
/ Luminescent Measurements
/ Male
/ Medical research
/ Middle Aged
/ NMR
/ Nuclear magnetic resonance
/ Original
/ Patients
/ Polypeptides
/ Protein Precursors - blood
/ Prothrombin
/ ROC Curve
/ Sensitivity and Specificity
/ Studies
/ Surveillance
/ Technology transfer
/ Tumors
/ Ultrasonic imaging
/ Viral infections
2017
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Serum monomeric laminin‐γ2 as a novel biomarker for hepatocellular carcinoma
Journal Article
Serum monomeric laminin‐γ2 as a novel biomarker for hepatocellular carcinoma
2017
Request Book From Autostore
and Choose the Collection Method
Overview
The diagnosis of hepatocellular carcinoma (HCC) in the early stages is important for successful clinical management. Laminin (Ln)‐γ2 expression has been reported in various types of malignant carcinomas. We recently developed a highly sensitive method to measure serum monomeric Ln‐γ2 levels using a fully automated chemiluminescent immunoassay (CLIA). Using our CLIA, we evaluated its diagnostic value in sera from patients with chronic liver disease (CLD) and patients with hepatocellular carcinoma (HCC). Serum alpha‐fetoprotein (AFP) and des‐gamma‐carboxy prothrombin (DCP) were also examined in these subjects. Median levels of Ln‐γ2 were significantly higher in patients with HCC (173.2 pg/mL; range: 39.5–986 pg/mL) compared with patients with CLD (76.7 pg/mL; range: 38.7–215.9 pg/mL) and with healthy volunteers (41.1 pg/mL; range: 10.9–79.0 pg/mL). The optimal cutoff value for Ln‐γ2 that allowed us to distinguish between HCC and nonmalignant CLD was 116.6 pg/mL. Elevated Ln‐γ2 levels were observed in 0% of healthy volunteers, 17% of patients with CLD, and 63% of patients with HCC. The positivity rate in patients with HCC for the combination of Ln‐γ2 and DCP was 89.5%, which was better than that for either of the two markers alone (63% and 68%, respectively). Among patients with early‐stage HCC (T1 or T2), the positivity rates for monomeric Ln‐γ2, AFP and DCP were 61%, 39% and 57%, respectively. Serum Ln‐γ2 may be a potential biomarker for HCC surveillance. The combination of Ln‐γ2 and DCP may be more sensitive for laboratory diagnosis of HCC than the combination of AFP and DCP. Serum monomeric Ln‐γ2 may be a potential biomarker for HCC surveillance. The combination of monomeric Ln‐γ2 and DCP may be more sensitive for laboratory diagnosis of HCC than the combination of AFP and DCP.
This website uses cookies to ensure you get the best experience on our website.